Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities

被引：87
作者：
Nie, Zhe [1 ]
Perretta, Carin [1 ]
Erickson, Philip [1 ]
Margosiak, Stephen [2 ]
Lu, Jia [2 ]
Averill, April [2 ]
Almassy, Robert [3 ]
Chua, Shaosong [1 ]
机构：
[1] Polaris Pharmaceut Inc, Dept Med Chem, San Diego, CA 92121 USA
[2] Polaris Pharmaceut Inc, Dept Prot Chem, San Diego, CA 92121 USA
[3] Polaris Pharmaceut Inc, Dept Biol Struct, San Diego, CA 92121 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 02期
关键词：
CK2; kinase; anticancer;
D O I：
10.1016/j.bmcl.2007.11.074
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of macrocyclic derivatives has been designed and synthesized based on the X-ray co-crystal structures of pyrazolo[1,5-a] [1,3,5]triazines with corn CK2 (cCK2) protein. Bioassays demonstrated that these macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds are potent CK2 inhibitors with K-i around 1.0 nM and strongly inhibit cancer cell growth with IC50 as low as similar to 100 nM. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：619 / 623
页数：5
相关论文
共 15 条
  • [1] Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2
    Nie, Zhe
    Perretta, Carin
    Erickson, Philip
    Margosiak, Stephen
    Almassy, Robert
    Lu, Jia
    Averill, April
    Yager, Kraig M.
    Chu, Shaosong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) : 4191 - 4195
  • [2] Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo
    Dowling, James E.
    Alimzhanov, Marat
    Bao, Larry
    Block, Michael H.
    Chuaqui, Claudio
    Cooke, Emma L.
    Denz, Christopher R.
    Hird, Alex
    Huang, Shan
    Larsen, Nicholas A.
    Peng, Bo
    Pontz, Timothy W.
    Rivard-Costa, Caroline
    Saeh, Jamal Carlos
    Thakur, Kumar
    Ye, Qing
    Zhang, Tao
    Lyne, Paul D.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (08): : 800 - 805
  • [3] Design, synthesis and molecular docking of novel pyrazolo [1,5-a] [1,3,5] triazine derivatives as CDK2 inhibitors
    Oudah, Khulood H.
    Najm, Mazin A. A.
    Samir, Nermin
    Serya, Rabah A. T.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2019, 92
  • [4] Synthesis, anticancer activity and molecular docking of new pyrazolo[1,5-a]pyrimidine derivatives as EGFR/HER2 dual kinase inhibitors
    Sivaiah G.
    Raveesha R.
    Prasad S.B.B.
    Kumar K.Y.
    Raghu M.S.
    Alharethy F.
    Prashanth M.K.
    Jeon B.-H.
    Journal of Molecular Structure, 2023, 1289
  • [5] 7-(2-Aryl-1-cyanovinyl)-1,2,3,4-tetrahydropyrazolo[1,5-a][1,3,5]triazine-8-carbonitriles: Synthesis and Biological Activity
    Stepanova, S. F.
    Semenova, A. M.
    Dotsenko, V. V.
    Strelkov, V. D.
    Temerdashev, A. Z.
    Gasyuk, O. A.
    Volchenko, N. N.
    Aksenov, N. A.
    Aksenova, I. V.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2023, 93 (06) : 1360 - 1373
  • [6] Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity
    Ali, Ghada M. E.
    Ibrahim, Diaa A.
    Elmetwali, Amira M.
    Ismail, Nasser S. M.
    BIOORGANIC CHEMISTRY, 2019, 86 : 1 - 14
  • [7] 1,3,5-triazine derivatives as potential anticancer agents against lung and breast cancer cell lines: Synthesis, biological evaluation, and structure-based drug design studies
    Sharma, Omprakash
    Srivastava, Shubham
    Sharma, Manish
    Malik, Ruchi
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1308
  • [8] Design, Synthesis and Molecular Docking Study of Novel 1,3,5-Triazine and 2-Phenylquinazoline Derivatives as Promising Anticancer Agents
    Abdel-Karim, Marwa M.
    Elmorsy, Mohammad A.
    Selim, Khalid B.
    Eisa, Hassan M.
    POLYCYCLIC AROMATIC COMPOUNDS, 2025,
  • [9] Quinazoline based 1,3,5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study
    Pathak, Prateek
    Naumovich, Vladislav
    Grishina, Maria
    Shukla, Parjanya Kumar
    Verma, Amita
    Potemkiri, Vladimir
    ARCHIV DER PHARMAZIE, 2019, 352 (09)
  • [10] Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo
    Liu, Qing-Qing
    Lu, Ke
    Zhu, Hai-Miao
    Kong, Shi-Lin
    Yuan, Jing-Mei
    Zhang, Guo-Hai
    Chen, Nan-Ying
    Gu, Chen-Xi
    Pan, Cheng-Xue
    Mo, Dong-Liang
    Su, Gui-Fa
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 165 : 293 - 308
12